Acasti Pharma Other Current Assets 2014-2024 | GRCE
Acasti Pharma other current assets from 2014 to 2024. Other current assets can be defined as field containing the sum of all current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
Acasti Pharma Annual Other Current Assets (Millions of US $) |
2024 |
$ |
2023 |
$ |
2022 |
$0 |
2021 |
$1 |
2020 |
$3 |
2019 |
$0 |
2018 |
$0 |
2017 |
$ |
2016 |
$ |
2015 |
$0 |
2015 |
$ |
2014 |
$1 |
2014 |
$ |
2013 |
$0 |
2013 |
$ |
Acasti Pharma Quarterly Other Current Assets (Millions of US $) |
2024-06-30 |
|
2024-03-31 |
|
2023-12-31 |
|
2023-09-30 |
|
2023-06-30 |
|
2023-03-31 |
|
2022-12-31 |
$0 |
2022-09-30 |
$0 |
2022-06-30 |
$0 |
2022-03-31 |
$0 |
2021-12-31 |
$1 |
2021-09-30 |
$1 |
2021-06-30 |
$1 |
2021-03-31 |
$1 |
2020-12-31 |
$1 |
2020-09-30 |
$1 |
2020-06-30 |
$0 |
2020-03-31 |
$3 |
2019-12-31 |
$0 |
2019-09-30 |
$0 |
2019-06-30 |
$0 |
2019-03-31 |
$0 |
2018-12-31 |
$0 |
2018-09-30 |
$0 |
2018-06-30 |
$0 |
2018-03-31 |
$0 |
2017-12-31 |
$0 |
2017-09-30 |
|
2017-06-30 |
|
2017-02-28 |
|
2016-11-30 |
|
2016-08-31 |
|
2016-05-31 |
|
2016-03-31 |
$0 |
2016-02-29 |
|
2015-12-31 |
$0 |
2015-09-30 |
$0 |
2015-06-30 |
$0 |
2015-03-31 |
$0 |
2014-12-31 |
$0 |
2014-09-30 |
$0 |
2014-06-30 |
$0 |
2014-03-31 |
$1 |
2014-02-28 |
|
2013-12-31 |
$0 |
2013-09-30 |
$0 |
2013-06-30 |
$0 |
2013-03-31 |
$0 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED-GENERIC DRG |
$0.033B |
$0.000B |
Acasti Pharma Inc. is a biopharmaceutical company. It is focused on research, development and commercialization of krill oil based forms of omega-3 phospholipid therapies. CaPre (R), Acasti's only prescription drug candidate, is being developed to help prevent and treat hypertriglyceridemia. ONEMIA (R) is a medical food and currently Acasti's only commercialized product. Acasti Pharma Inc. is headquartered in Laval, Canada.
|